Gujarat Terce Laboratories Stock Screener | Share Price & Fundamental Analysis
GUJTERC
Pharmaceuticals
Screen Gujarat Terce Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹47.89
▲
2.06 (4.49%)
Market Cap
₹13.99 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.66
EPS (TTM)
₹-1.32
Dividend Yield
-
Debt to Equity
0.35
52W High
₹84.85
52W Low
₹39.26
Operating Margin
16.00%
Profit Margin
20.00%
Revenue (TTM)
₹10.00
EBITDA
₹2.00
Net Income
₹2.00
Total Assets
₹23.00
Total Equity
₹7.00
Gujarat Terce Laboratories Share Price History - Stock Screener Chart
Screen GUJTERC historical share price movements with interactive charts. Analyze price trends and patterns.
Gujarat Terce Laboratories Company Profile - Fundamental Screener
Screen Gujarat Terce Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GUJTERC shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE499G01013
Gujarat Terce Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GUJTERC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 23 | 23 | 29 | 27 | 22 | 23 | 19 | 20 | 24 | 25 |
| Current Assets | 12 | 11 | 16 | 16 | 12 | 12 | 9 | 10 | 13 | 15 |
| Fixed Assets | 4 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 6 | 6 |
| Liabilities | ||||||||||
| Total Liabilities | 23 | 23 | 29 | 27 | 22 | 23 | 19 | 20 | 24 | 25 |
| Current Liabilities | 4 | 4 | 5 | 6 | 3 | 2 | 2 | 2 | 8 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 7 | 7 | 7 | 9 | 8 | 11 | 11 | 10 | 10 | 10 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | 0 | -1 | 1 | 0 | 4 | 3 | 3 | 3 | 3 |
Screen GUJTERC income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2021-Jun | 2021-Sept | 2020-Mar | 2020-Jun | 2020-Sept | 2019-Mar | 2019-Jun | 2019-Sept | 2019-Dec | 2018-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 10 | 10 | 5 | 7 | 8 | 7 | 11 | 10 | 8 |
| Expenses | 8 | 10 | 10 | 5 | 7 | 8 | 8 | 9 | 10 | 8 |
| EBITDA | 2 | 1 | 0 | 0 | 0 | 0 | -1 | 2 | 1 | 1 |
| Operating Profit % | 16.00% | 5.00% | -5.00% | -8.00% | 2.00% | 2.00% | -16.00% | 17.00% | 4.00% | 8.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 0 | 0 | 0 | 0 | 0 | -1 | 2 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 0 | -1 | 0 | 0 | 0 | -1 | 2 | 0 | 1 |
| EPS | 2.16 | 0.61 | 0.00 | -0.60 | -0.02 | 0.49 | 0.00 | 2.28 | 0.50 | 0.77 |
Gujarat Terce Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen GUJTERC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 3 | 0 | 0 | 0 | -2 | -1 | 5 | 0 | 0 |
| Investing Activities | 1 | -1 | 1 | -1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Financing Activities | -3 | -4 | 0 | 2 | 2 | 2 | 0 | -5 | 0 | -1 |
| Net Cash Flow | 1 | -2 | 1 | 0 | 1 | 0 | -1 | 0 | 0 | -1 |
Screen GUJTERC shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 37.03% | 37.03% | 37.03% | 40.03% | 37.03% | 37.03% | 37.03% | 37.03% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 59.34% | 59.12% | 58.49% | 55.71% | 59.92% | 59.87% | 59.62% | 59.44% |
| Other Holding | 3.63% | 3.85% | 4.48% | 4.27% | 3.05% | 3.10% | 3.35% | 3.53% |
| Shareholder Count | 13,764 | 13,804 | 13,812 | 13,812 | 13,203 | 13,394 | 13,538 | 13,710 |
Gujarat Terce Laboratories Dividend Screener - Share Yield Analysis
Screen GUJTERC dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Gujarat Terce Laboratories Index Membership - Market Screener Classification
Screen GUJTERC by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Gujarat Terce Laboratories Market Events Screener - Corporate Actions
Screen GUJTERC market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 42.75% | ||
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | 0.50% |
| 2025-08-21 | 2025-08-21 | Annual General Meeting | NA | -11.91% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -3.34% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -2.57% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -6.07% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -9.08% |
| 2024-04-25 | 2024-04-25 | Extraordinary General Meeting | NA | 27.38% |
Gujarat Terce Laboratories Competitors Screener - Peer Comparison
Screen GUJTERC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Gujarat Terce Laboratories Company Announcements - News Screener
Screen GUJTERC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-02 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-08 | Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025 - Regulations 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-08 | Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 8 November 2025 | View |
| 2025-11-02 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2025 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Closure of Trading Window | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-01 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2025-09-01 | Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 1 September 2025 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - C | View |
| 2025-08-22 | Shareholders Meeting - 40Th AGM Scrutinizer Report Along With Voting Results | View |
| 2025-08-21 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-21 | Announcement Under Regulation 30 Of SEBI (LODR)- Cessation Of Mrs. Chhayaben Shah (DIN: 01435892) Independent Director Due To Expiry Of Term | View |
| 2025-08-21 | Cessation Of Mrs. Chhayaben Shah (DIN: 01435892) Independent Director Due To Expiry Of Term | View |
| 2025-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |